Evidence map›Paper›PMID 26825532›Full record

ArticleJournal of the American Society of Nephrology : JASN2016

Distinct Requirements for Vacuolar Protein Sorting 34 Downstream Effector Phosphatidylinositol 3-Phosphate 5-Kinase in Podocytes Versus Proximal Tubular Cells.

Madhusudan Venkatareddy, Rakesh Verma, Anne Kalinowski, Sanjeevkumar R Patel, Assia Shisheva, Puneet Garg

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Madhusudan VenkatareddyDivision of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan; and.
Rakesh VermaDivision of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan; and.
Anne KalinowskiDivision of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan; and.
Sanjeevkumar R PatelDivision of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan; and.
Assia ShishevaDepartment of Physiology, Wayne State University School of Medicine, Detroit, Michigan.
Puneet GargDivision of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan; and pungarg@umich.edu.
University of Michigan–Ann Arbor · USWayne State University · US

Funding

PUBLIC HEALTH DEMONSTRATIONP60DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MYERS, MARTIN G · 1985 to 2012
$26.5M
Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAVID P OLSON · 2013 to 2026
$24.3M
University of Michigan O'Brien Kidney Translational Core CenterP30DK081943 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PENNATHUR, SUBRAMANIAM · 2008 to 2022
$12.9M
Shp2 a Non-Receptor Tyrosine Phosphatase Regulates Nephrin Phosphorylation and PoR01DK097027 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GARG, PUNEET · 2014 to 2018
$1.7M
Mechanism of Gene Repression in the KidneyR01DK082409 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PATEL, SANJEEVKUMAR R · 2009 to 2013
$1.5M
Role of Endocytosis and Vesicular Trafficking in Podocyte Health and Filter IntegR03DK096053 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GARG, PUNEET · 2012 to 2012
$77k
NIDDK NIH HHS P30 DK020572NIDDK NIH HHS P30 DK081943NIDDK NIH HHS P60 DK020572NIDDK NIH HHS R01 DK082409NIDDK NIH HHS R01 DK097027NIDDK NIH HHS R03 DK096053
6 · The paper itself

Abstract

The mechanisms by which the glomerular filtration barrier prevents the loss of large macromolecules and simultaneously, maintains the filter remain poorly understood. Recent studies proposed that podocytes have an active role in both the endocytosis of filtered macromolecules and the maintenance of the filtration barrier. Deletion of a key endosomal trafficking regulator, the class 3 phosphatidylinositol (PtdIns) 3-kinase vacuolar protein sorting 34 (Vps34), in podocytes results in aberrant endosomal membrane morphology and podocyte dysfunction. We recently showed that the vacuolation phenotype in cultured Vps34-deficient podocytes is caused by the absence of a substrate for the Vps34 downstream effector PtdIns 3-phosphate 5-kinase (PIKfyve), which phosphorylates Vps34-generated PtdIns(3)P to produce PtdIns (3,5)P2. PIKfyve perturbation and PtdIns(3,5)P2 reduction result in massive membrane vacuolation along the endosomal system, but the cell-specific functions of PIKfyve in vivo remain unclear. We show here that the genetic deletion of PIKfyve in endocytically active proximal tubular cells resulted in the development of large cytoplasmic vacuoles caused by arrested endocytic traffic progression at a late-endosome stage. In contrast, deletion of PIKfyve in glomerular podocytes did not significantly alter the endosomal morphology, even in age 18-month-old mice. However, on culturing, the PIKfyve-deleted podocytes developed massive cytoplasmic vacuoles. In summary, these data suggest that glomerular podocytes and proximal tubules have different requirements for PIKfyve function, likely related to distinct in vivo needs for endocytic flux.

Indexed as

AnimalsClass III Phosphatidylinositol 3-KinasesEndosomesKidney GlomerulusKidney Tubules, ProximalMicePhosphatidylinositol 3-KinasesPodocytesClass III Phosphatidylinositol 3-KinasesPhosphatidylinositol 3-KinasesPikfyve protein, mouseglomeruluspodocyteproteinuria

Identifiers

PMID26825532
PMCPMC5004647
OpenAlexW2278108486

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.